menu
    • menu

    Company profile for Ionis Pharmaceuticals

    NEW Drugs in Dev: 63
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are the leading company in RNA-targeted drug discovery and development with a pipeline of first-in-class or best-in-class medicines with the potential to provide high value for patients with significant unmet medical needs. We have created an efficient and broadly applicable drug discovery platform. Using this platform, we believe that we are revolutionizing medicine with the goal to improve the quality of, and save, lives.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ionis PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2855 Gazelle Court Carlsbad, CA 92010
    Telephone
    Telephone
    760-931-9200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ionispharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ionis-pharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ionispharma?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ionis Doubles Its Sales Projection for Tryngolza in sHTG to $2B
    Ionis Doubles Its Sales Projection for Tryngolza in sHTG to $2B

    13 Jan 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/jpm26-ionis-bolstered-strong-launch-tryngolza-doubles-its-sales-projection-new-indication-2b

    FIERCE PHARMA
    13 Jan 2026
    Share Share
    GSK & Ionis's 'Functional Cure' For Hep B Proves Worth In Ph. 3
    GSK & Ionis's 'Functional Cure' For Hep B Proves Worth In Ph. 3

    07 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260106121974/en/Ionis-partner-GSK-announces-positive-topline-results-from-B-Well-1-and-B-Well-2-Phase-3-studies-for-bepirovirsen-a-potential-first-in-class-medicine-for-chronic-hepatitis-B

    BUSINESSWIRE
    07 Jan 2026
    Share Share
    Ionis To Present At 44th Annual J.P. Morgan Healthcare Conference
    Ionis To Present At 44th Annual J.P. Morgan Healthcare Conference

    06 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260106304033/en/Ionis-to-present-at-44th-Annual-J.P.-Morgan-Healthcare-Conference

    BUSINESSWIRE
    06 Jan 2026
    Share Share
    Ionis Ramps Up Angelman Syndrome Awareness With Lifetime Segment
    Ionis Ramps Up Angelman Syndrome Awareness With Lifetime Segment

    17 Dec 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/marketing/pivotal-trial-underway-ionis-ramps-angelman-syndrome-awareness-lifetime-tv-segment

    FIERCE PHARMA
    17 Dec 2025
    Share Share
    Deciphera Presents Positive Phase 2A Sapablursen Results
    Deciphera Presents Positive Phase 2A Sapablursen Results

    06 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251206361611/en/Deciphera-Announces-Oral-Presentation-of-Positive-Topline-Results-from-Phase-2a-Study-of-Sapablursen-in-Polycythemia-Vera-at-the-67th-American-Society-of-Hematology-ASH-Annual-Meeting

    BUSINESSWIRE
    06 Dec 2025
    Share Share
    Ionis Granted FDA Breakthrough Therapy Designation for AxD
    Ionis Granted FDA Breakthrough Therapy Designation for AxD

    02 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251202774475/en/Ionis-receives-U.S.-FDA-Breakthrough-Therapy-designation-for-zilganersen-for-Alexander-disease-AxD

    BUSINESSWIRE
    02 Dec 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Ionis Pharmaceuticals and get a quotation

    Ionis Pharmaceuticals is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Nusinersen bulk offered by Ionis Pharmaceuticals

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search